首页|A PhaseIISingle Arm Pilot Study of theCHK1Inhibitor Prexasertib (LY2606368) inBRCAWild-Type, AdvancedTriple-NegativeBreast Cancer

A PhaseIISingle Arm Pilot Study of theCHK1Inhibitor Prexasertib (LY2606368) inBRCAWild-Type, AdvancedTriple-NegativeBreast Cancer

扫码查看
Lessons Learned

Gatti-Mays, Margaret E.、Karzai, Fatima H.、Soltani, Sanaz N.、Zimmer, Alexandra、Green, Jeffrey E.、Lee, Min-Jung、Trepel, Jane B.、Yuno, Akira、Lipkowitz, Stanley、Nair, Jayakumar、McCoy, Ann、Lee, Jung-Min

展开 >

NCI, Lab Tumor Immunol & Biol, NIH, Bethesda, MD 20892 USA

NCI, Genitourinary Malignancies Branch, NIH, Bethesda, MD 20892 USA

NCI, Womens Malignancies Branch, NIH, Bethesda, MD 20892 USA

NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA

NCI, Dev Therapeut Branch, NIH, Bethesda, MD 20892 USA

展开 >

2020

The oncologist

The oncologist

ISSN:1083-7159
年,卷(期):2020.25(12)
  • 9
  • 18